Sabrina Fabbri

Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies

Maria Pia Sormani, Matilde Inglese, Irene Schiavetti et al. · EBioMedicine · 2021 · 224 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy

Maria Pia Sormani, Irene Schiavetti, Matilde Inglese et al. · EBioMedicine · 2022 · 82 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Correspondence between neurophysiological and clinical measurements of chemotherapy‐induced peripheral neuropathy: secondary analysis of data from the <scp>CI‐PeriNomS</scp> study

Kathleen A. Griffith, Susan G. Dorsey, Cynthia L. Renn et al. · Journal of the Peripheral Nervous System · 2014 · 44 citations · Full text

Medicine, Neurology, Chemotherapy +16

Tailoring B cell depletion therapy in MS according to memory B cell monitoring

Giovanni Novi, Francesca Bovis, Sabrina Fabbri et al. · Neurology Neuroimmunology & Neuroinflammation · 2020 · 43 citations · Full text

Life Sciences, Hematology, Immunology +17

An integrated approach to the evaluation of patients with asymptomatic or minimally symptomatic <scp>hyperCKemia</scp>

Chiara Gemelli, Monica Traverso, Lucia Trevisan et al. · Muscle & Nerve · 2021 · 22 citations · Full text

Medicine, Genetics, Neurology +17